DESAI RANJIT C.,SRIVASTAVA BRIJESH K.,PATEL PANKAJ R
申请号：
NZ70825513
公开号：
NZ708255A
申请日:
2013.12.23
申请国别(地区):
NZ
年份:
2016
代理人:
摘要：
The present invention relates to compounds of general formula (I), their stereoisomers, regioisomers, tautomeric forms and intermediates involved in their synthesis, their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and pharmaceutical compositions containing them. The present invention also relates to a process of preparing compounds of general formula (I), their stereoisomers, regioisomers, their tautomeric forms, their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, pharmaceutical compositions containing them, and intermediates involved in their synthesis. The compounds of formula (I) are useful as PARP-1 inhibitors for the treatment of, e.g. cancer.
